The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...

Hearing that two people have the same type of cancer often leads to one assumption: they'll receive the same treatment. However, modern oncology has moved fa ...

A first-in-class nanoparticle injection sneaks antibodies into pancreatic cancer cells to clear mutant KRAS, shrinking tumors ...

Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked. A new study takes a deep dive into inherited cancer mutations ...

Studies of genetics conducted in yeast cells, human neurons, mice or other model systems often reveal networks of genes that ...

Researchers have found that a genetic mutation associated with a rare group of blood cancers does not always result in ...

Epithelial ovarian cancer (EOC) genetics research has been focused on germline or somatic mutations independently. Emerging evidence suggests that the somatic mutational landscape can be shaped by the ...

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

Comprehensive maps of mutations in healthy and diseased gastric tissue give clues about how cancer arises and could inform early-detection strategies. Read the paper: The somatic mutation landscape of ...

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how the drug works.

Blackstone Inc. President Jon Gray has steered his firm to more artificial-intelligence investments, and the same is true ...